FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 4th, 2021 • Surface Oncology, Inc. • Biological products, (no disgnostic substances) • New York
This First Amendment to Loan And Security Agreement (this “Amendment”) is entered into as of October 1, 2021 (the “First Amendment Effective Date”), by and among SURFACE ONCOLOGY, INC., a Delaware corporation (“Borrower Representative”), K2 HEALTHVENTURES LLC, as administrative agent for Lenders (in such capacity, together with its successors, “Administrative Agent”), and the undersigned Lenders, constituting Required Lenders.
